Wolverine Trading, LLC Paratek Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.94 - $4.77 $41,289 - $66,989	-14,044 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $5,482 - $7,139	-1,347 Reduced 8.75%	14,044 $62,000
Q2 2021 Aug 06, 2021	BUY	$6.81 - $10.93 $30,481 - $48,922	4,476 Added 41.01%	15,391 $105,000
Q1 2021 May 14, 2021	SELL	$6.14 - $8.31 $46,817 - $63,363	-7,625 Reduced 41.13%	10,915 $75,000
Q4 2020 Feb 12, 2021	BUY	$4.58 - $7.14 $23,509 - $36,649	5,133 Added 38.29%	18,540 $115,000
Q3 2019 Nov 14, 2019	SELL	$3.08 - $5.76 $46,005 - $86,037	-14,937 Reduced 52.7%	13,407 $62,000
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $93,884 - $113,595	10,374 Added 57.73%	28,344 $275,000
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $20,050 - $29,877	1,585 Added 9.67%	17,970 $234,000
Q3 2017 Nov 15, 2017	BUY	$18.9 - $28.2 $309,676 - $462,057	16,385	16,385 $411,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.